SPEAKER: Associate Professor Michelle E. Farkas, Department of Chemistry, University of Massachusetts Amherst, USA
SUMMARY: As biology is by nature dynamic, so must be the nature of the tools used for its tracking and modulation. My lab is interested in the development of platforms for following and studying circadian rhythms in the context of cancer. It is appreciated that altered circadian rhythms can contribute to a variety of disease pathologies, including cancer. We are using and developing reporter systems to gain a more detailed picture of oscillations and how they change with cancer type. We are also interested in the use of small molecules and other approaches to directly affect circadian rhythms.
The seminar is open to interested colleagues and students!
TheISMLunchtimeSeminarsare online monthly events, which take place onThursdays, 13:00-13:30h, andare open to all interested colleagues andstudents. ISM researchersand guest speakerspresent their work during a15 minseminar,intheEnglish language,followed by abriefQ&A session. We are happy to announce ournextspeaker: Prof. Dr. Angela Relόgio, Professor for Systems Medicine and Biostatistics
Title:Timing treatment: profiling the circadian clockand optimizing treatment timing in cancer.
Abstract:The biological clock (circadian clock) regulates several aspects of physiology and behaviour and plays avital role in human health. About half of all human genes are rhythmically expressed in at least one tissue, and the time for certain activities such as sleep, exercise, or medicine intake, can be optimized based on the internal circadian rhythm. Recent studies, including work from our group have highlighted a role for clock dysregulation in several hallmarks of cancer related to cell cycle, apoptosis or metabolism. Thus, scheduling anticancer drug administration over 24h may critically impact treatment success in a drug-and patient-specific manner.Our results suggest that, in addition to clock and pharmacological gene expression, the circadian dynamics of translation and cell death, plays an important role in the timing of drug toxicity. Systems biology approaches addressing the personalization of cancer chronotherapies are needed for patient benefit, and canbe used to support personalized treatment scheduling, by predicting personalized drug toxicity based on the patient’s gene or protein expression profiles
Please follow the rules below to make these seminars a success: -Please use your real name while entering the meeting. Participants with cryptic names will not be given access to the seminar. -Please turn off your microphone while the seminar istaking place. -Please feel free to ask questions! Contact information Please contactDr.Deeksha Malhan (firstname.lastname@example.org)orDr.Annakarina Mundorf (email@example.com) for further information.
The German Conference on Bioinformatics (GCB) is an annual, international conference devoted to all areas of bioinformatics and meant as a platform for the whole bioinformatics community. Recent meetings attracted a multinational audience of approx. 250 participants each year.
The conference will take place at the DESY research facility, one of the world’s leading accelerator centres. Besides the talks and poster sessions, ample networking opportunities including a conference dinner, a guided tour through DESY’s accelerator labs, and a company exhibition to connect with industry representatives will be provided. The conference is preceded by a workshop programme on the 11 September 2023.